Evidence map›Paper›PMID 31064747›Full record

ArticleBlood advances2019

Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.

Malgorzata Kasztan, Brandon M Fox, Jeffrey D Lebensburger, Kelly A Hyndman, Joshua S Speed, Jennifer S Pollock, David M Pollock

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Blood advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07175051 (Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07175051 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2026 to 2030Enrolled20ConditionsSickle Cell Anemia (HbSS, or HbSβ-thalassemia0), AlbuminuriaArmsEmpagliflozin (oral)
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Impact of renal iron overload on sickle cell nephropathy in a humanized mouse model.American journal of physiology. Renal physiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Diurnal function and expression of aquaporins in the mouse kidney.American journal of physiology. Renal physiology · 2025
    Article
  7. Article
  8. Article
  9. Endothelin-1 signaling in the kidney: recent advances and remaining gaps.American journal of physiology. Renal physiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Glomerular hyperfiltration: part 2-clinical significance in children.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Malgorzata KasztanCardio-Renal Physiology and Medicine, Department of Medicine, and.
Brandon M FoxCardio-Renal Physiology and Medicine, Department of Medicine, and.
Jeffrey D LebensburgerDivision of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL.
Kelly A HyndmanCardio-Renal Physiology and Medicine, Department of Medicine, and.
Joshua S SpeedCardio-Renal Physiology and Medicine, Department of Medicine, and.
Jennifer S PollockCardio-Renal Physiology and Medicine, Department of Medicine, and.
David M PollockCardio-Renal Physiology and Medicine, Department of Medicine, and.ORCID 0000-0002-0233-2362
Metabolism and Renal Physiology · FRUniversity of Alabama at Birmingham · US

Funding

UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MEHTA, RAVINDRA L. · 2008 to 2022
$18.3M
The Role of Endothelin-1 in Sickle Cell DiseaseU01HL117684 · NHLBI · AUGUSTA UNIVERSITY · PI KUTLAR, ABDULLAH, MEILER, STEFFEN · 2013 to 2017
$8.1M
Chronobiology and Chronopharmacology to Prevent Sickle Cell NephropathyK23HL127100 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEBENSBURGER, JEFFREY D · 2015 to 2019
$916k
Endothelin - Mechanisms in Hypertension and ObesityR00HL127178 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI SPEED, JOSHUA S · 2018 to 2020
$878k
Novel mechanisms of HDAC1 regulation of renal collecting duct functionK01DK105038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HYNDMAN, KELLY · 2015 to 2019
$754k
Novel Mechanisms of Decreased NO Bioavailability in Sickle Cell NephropathyF30DK107194 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FOX, BRANDON M · 2015 to 2018
$153k
NHLBI NIH HHS K23 HL127100NHLBI NIH HHS R00 HL127178NHLBI NIH HHS U01 HL117684NIDDK NIH HHS F30 DK107194NIDDK NIH HHS K01 DK105038NIDDK NIH HHS P30 DK079337
6 · The paper itself

Abstract

We previously reported that humanized sickle cell (HbSS) mice develop spontaneous nephropathy, a major cause of morbidity and mortality in sickle cell disease (SCD). Because sex-dependent protective mechanisms in SCD have been reported, we examined the course of nephropathy in male and female HbSS mice to determine contributors and/or predictors of disease severity. In male HbSS mice, glomerular filtration rate was characterized by a rapid onset of hyperfiltration and subsequent progressive decline of renal function over 20 weeks. Early tubular injury presented with increased excretion of kidney injury marker 1 (KIM-1), progressive loss of tubular brush border, and interstitial fibrosis that preceded the onset of glomerular damage, suggesting a tubuloglomerular mechanism of kidney injury in these mice. Additionally, we observed a strong association between the magnitude of hyperfiltration and the degree of long-term kidney injury in male HbSS mice. Unlike males, female HbSS mice did not demonstrate a significant loss of renal function or severe kidney damage during the time course of the study. These results suggest that magnitude of hyperfiltration predicts the onset of chronic kidney damage in male HbSS mice, whereas protective mechanisms in female HbSS mice delay the onset of SCD nephropathy.

Indexed as

Anemia, Sickle CellAnimalsDisease Models, AnimalFemaleGlomerular Filtration RateHemoglobin, SickleHepatitis A Virus Cellular Receptor 1HumansKidneyKidney DiseasesKidney Tubules, ProximalLongitudinal StudiesMaleMembrane ProteinsMiceMice, Inbred C57BLHavcr1 protein, mouseHemoglobin, SickleHepatitis A Virus Cellular Receptor 1Membrane Proteinsnephrin

Identifiers

PMID31064747
PMCPMC6517665
OpenAlexW2944768214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.